Eisai (4523.T) Financial Analysis & Valuation | Quarter Chart
Eisai (4523.T)
4523.TPrice: $25.45
Fair Value: 🔒
🔒score
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary gene... more
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzh... more
Description
Shares
| Market Cap | $7.18B | Exchange | JPX |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | JP | CEO | Haruo Naito |
| IPO Date | 2000-01-04 | CAGR | 0.04% |
| Employees | 11,067 | Website | www.eisai.co.jp |
| Div. Yield | 4.85% | Payout Ratio | 1.17% |
| Buy Back Yield | — | Total Yield | 4.85% |
4523.T chart loading...
Fundamentals
Technicals
| Enterprise Value | $1313.85B | P/E Ratio | 29.81 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 1.14 | P/B Ratio | 1.04 |
| P/CF Ratio | 15.16 | P/FCF Ratio | 20.23 |
| EPS | $0.85 | EPS Growth 1Y | -16.53% |
| EPS Growth 3Y | -29.25% | EPS Growth 5Y | -6.93% |
| Revenue Growth 1Y | 4.56% | Gross Margin | 0.77% |
| Operating Margin | 0.05% | Profit Margin | 0.05% |
| ROE | 0.04% | ROA | 0.03% |
| ROCE | 0.04% | Current Ratio | 2.24 |
| Quick Ratio | 1.48 | Cash Ratio | 0.72 |
| Debt/Equity | 0.21 | Interest Coverage | 7.54 |
| Altman Z Score | 2.8 | Piotroski Score | 7 |